NetScientific, a UK-based commercialisation firm chaired by former GlaxoSmithKline chairman Richard Sykes, has unveiled plans to raise £30m ($47m) in an initial public offering on London’s AIM market, valuing the company at £57.5m.
The company, which maintains a presence in Cambridge and New York in addition to its Amersham HQ, develops and commercialises research and technology emanating from a number of UK universities, hospitals, and research institutes, as well as Drexel University in the US.
The IPO will be used…
